Cargando…

Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

BACKGROUND: In view of the fact that peripheral blood parameters have been reported as predictors of immunotherapy to various cancers, this study aimed to determine the predictors of response to anti-programmed death-1 (anti-PD-1) therapy in patients with esophageal squamous cell carcinoma (ESCC) fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xianbin, Han, Runkun, Zhong, Yanping, Weng, Nuoqing, Zhang, Ao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262036/ https://www.ncbi.nlm.nih.gov/pubmed/34233686 http://dx.doi.org/10.1186/s12935-021-02072-x

Ejemplares similares

Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma
por: Wu, Xiaobin, et al.
Publicado: (2021)

CALM1 promotes progression and dampens chemosensitivity to EGFR inhibitor in esophageal squamous cell carcinoma
por: Liu, Tao, et al.
Publicado: (2021)

Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma
por: Baba, Yoshifumi, et al.
Publicado: (2020)

Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
por: Jiao, Ruidi, et al.
Publicado: (2019)

Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma
por: Zhang, Ao, et al.
Publicado: (2021)

Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells
por: Ding, Wen-Xiu, et al.
Publicado: (2019)

Genomic characterization of a newly established esophageal squamous cell carcinoma cell line from China and published esophageal squamous cell carcinoma cell lines
por: Li, Xiang, et al.
Publicado: (2020)

Immune checkpoint inhibitors for esophageal squamous cell carcinoma: a narrative review
por: Zhang, Wencheng, et al.
Publicado: (2020)

EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma
por: Deng, Mingming, et al.
Publicado: (2021)

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma
por: Zhao, Jing-Jing, et al.
Publicado: (2018)

Downregulation of microRNA-21 inhibited radiation-resistance of esophageal squamous cell carcinoma
por: Li, Fang, et al.
Publicado: (2018)

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
por: zhang, Lan, et al.
Publicado: (2020)

The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy
por: Gao, Qiu-Fang, et al.
Publicado: (2018)

POLE2 knockdown reduce tumorigenesis in esophageal squamous cells
por: Zhu, Yongjun, et al.
Publicado: (2020)

Identification of four genes and biological characteristics of esophageal squamous cell carcinoma by integrated bioinformatics analysis
por: Song, Yexun, et al.
Publicado: (2021)

CTCF-silenced miR-137 contributes to EMT and radioresistance in esophageal squamous cell carcinoma
por: Xu, Shuwen, et al.
Publicado: (2021)

High AKAP8L expression predicts poor prognosis in esophageal squamous cell carcinoma
por: Luo, Qiu-yun, et al.
Publicado: (2022)

Contribution of nestin positive esophageal squamous cancer cells on malignant proliferation, apoptosis, and poor prognosis
por: Zhong, Beilong, et al.
Publicado: (2014)

Single nucleotide polymorphism at alcohol dehydrogenase-1B is associated with risk of esophageal squamous cell carcinoma
por: Ye, Bo, et al.
Publicado: (2014)

miR-22 is down-regulated in esophageal squamous cell carcinoma and inhibits cell migration and invasion
por: Yang, Chao, et al.
Publicado: (2014)

Cellular and clinicopathological features of the IL-33/ST2 axis in human esophageal squamous cell carcinomas
por: Cui, Guanglin, et al.
Publicado: (2018)

An actin-binding protein ESPN is an independent prognosticator and regulates cell growth for esophageal squamous cell carcinoma
por: Li, Shau-Hsuan, et al.
Publicado: (2018)

Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy
por: Yang, Wanli, et al.
Publicado: (2019)

Dysfunction of apoptosis and autophagy correlates with local recurrence in esophageal squamous cell carcinoma after definitive chemoradiation
por: Qiu, Hu, et al.
Publicado: (2021)

Overexpression of long non-coding RNA SOX2OT promotes esophageal squamous cell carcinoma growth
por: Wu, Yuanyuan, et al.
Publicado: (2018)

Circular RNA circ_0006168 enhances Taxol resistance in esophageal squamous cell carcinoma by regulating miR-194-5p/JMJD1C axis
por: Qu, Fanyong, et al.
Publicado: (2021)

Efficacy and Safety of Immune Checkpoint Inhibitor in Advanced Esophageal Squamous Cell Carcinoma: A Meta-Analysis
por: Gu, Yi-Min, et al.
Publicado: (2021)

Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas
por: Lu, Tong, et al.
Publicado: (2019)

Circ0120816 acts as an oncogene of esophageal squamous cell carcinoma by inhibiting miR-1305 and releasing TXNRD1
por: Li, Xiaoyong, et al.
Publicado: (2020)

Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe
por: Deng, Zhaoming, et al.
Publicado: (2021)

SOCS6 promotes radiosensitivity and decreases cancer cell stemness in esophageal squamous cell carcinoma by regulating c-Kit ubiquitylation
por: Sun, Xuanzi, et al.
Publicado: (2021)

Immune-related lncRNA classification of head and neck squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

LncRNA GACAT3 promotes esophageal squamous cell carcinoma progression through regulation of miR-149/FOXM1
por: Su, Min, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Induced Lymphocytic Esophagitis
por: Amin, Shefali, et al.
Publicado: (2023)

Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
por: Zhu, Jian, et al.
Publicado: (2019)

Case Report: Immune Checkpoint Inhibitors Successfully Controlled Asymptomatic Brain Metastasis in Esophageal Squamous Cell Carcinoma
por: Xiao, Linlin, et al.
Publicado: (2022)

The long non-coding RNA AK001796 contributes to tumor growth via regulating expression of p53 in esophageal squamous cell carcinoma
por: Liu, Bin, et al.
Publicado: (2018)

MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth
por: Zhu, Jin-Feng, et al.
Publicado: (2018)

miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway
por: Zheng, Tian-Liang, et al.
Publicado: (2019)

Silencing of histone deacetylase 3 suppresses the development of esophageal squamous cell carcinoma through regulation of miR-494-mediated TGIF1
por: Yang, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_op9avfpq44cg3jskgc7igns2qb